Ribomic has raised its forecast for the current fiscal year's net loss to ¥1.44 billion. The net loss is now expected to be narrower than the previous forecast of ¥1.54 billion.
After the close on 20 October, Ribomic raised its forecast for net loss for the fiscal year ending March 2027 (non-consolidated) from the previous forecast of ¥1.54 billion to ¥1.44 billion. The previous fiscal year ended with a net loss of ¥1.14 billion. Accordingly, the net loss is expected to be narrower.
However, the company continued not to disclose an earnings outlook for the April–September period in this announcement. Market participants are watching for the timing of future disclosures and additional earnings information.